218 results match your criteria: "Michael G. DeGroote Institute for Pain Research and Care.[Affiliation]"
BMJ
August 2020
Department of Internal Medicine, American University of Beirut Medical Center, PO Box 11-0236, Riad-El-Solh Beirut 1107 2020, Beirut, Lebanon
Objective: To assess the risk of bias associated with missing outcome data in systematic reviews.
Design: Imputation study.
Setting: Systematic reviews.
J Hand Ther
October 2021
School of Rehabilitation, Université de Montréal, Succursale Centre-Ville, Montreal, Quebec, Canada.
Study Design: This is a systematic review performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses standards.
Introduction: Diverse approaches based on tactile stimulation are used in hand rehabilitation settings to treat touch-evoked dysesthesias. However, there is a lack of literature synthesis on the description and the effectiveness of the various approaches based on tactile stimulation that can be used for treating hand dysesthesia after nerve injury.
Br J Anaesth
November 2020
Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada.
Background: Despite common use, the benefit of adding steroids to local anaesthetics (SLA) for chronic non-cancer pain (CNCP) injections is uncertain. We performed a systematic review and meta-analysis of English-language RCTs to assess the benefit and safety of adding steroids to local anaesthetics (LA) for CNCP.
Methods: We searched MEDLINE, EMBASE, and CENTRAL databases from inception to May 2019.
Health Res Policy Syst
July 2020
Quality of Norms and Standards Department, Science Division, World Health Organization, Geneva, Switzerland.
Background: Without adequate reporting of research, valuable time and resources are wasted. In the same vein, adequate reporting of practice guidelines to optimise patient care is equally important. Our study examines the quality of reporting of published WHO guidelines, over time, using the RIGHT (Reporting Items for Practice Guidelines in HealThcare) reporting checklist.
View Article and Find Full Text PDFBr J Anaesth
September 2020
Department of Anesthesia, McMaster University, Hamilton, ON, Canada; Michael G. DeGroote Institute for Pain Research and Care, McMaster University, Hamilton, ON, Canada; Michael G. DeGroote Centre for Medicinal Cannabis Research, McMaster University, Hamilton, ON, Canada; Department of Health Research Methods, Evidence & Impact, McMaster University, Hamilton, ON, Canada.
Background: The prevalence and intensity of persistent post-surgical pain (PPSP) after breast cancer surgery are uncertain. We conducted a systematic review and meta-analysis to further elucidate this issue.
Methods: We searched MEDLINE, Embase, CINAHL, and PsycINFO, from inception to November 2018, for observational studies reporting persistent pain (≥3 months) after breast cancer surgery.
Gastroenterology
August 2020
Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada; Department of Anesthesia, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada; The Michael G. DeGroote Institute for Pain Research and Care, McMaster University, Hamilton, Ontario, Canada. Electronic address:
Background & Aims: We aimed to compare the effectiveness of single- vs multiple-strain probiotics in a network meta-analysis of randomized trials.
Methods: We searched MEDLINE, Embase, Science Citation Index Expanded, CINAHL, Scopus, Cochrane CENTRAL, BIOSIS Previews, and Google Scholar through January 1, 2019, for studies of single-strain and multistrain probiotic formulations on the outcomes of preterm, low-birth-weight neonates. We used a frequentist approach for network meta-analysis and the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach to assess the certainty of evidence.
Can J Anaesth
September 2020
MAGIC Evidence Ecosystem Foundation, Oslo, Norway.
PLoS One
August 2020
Michael G. DeGroote Institute for Pain Research and Care, McMaster University, Hamilton, Ontario, Canada.
Chronic neuropathic pain (NP) is a growing clinical problem for which effective treatments, aside from non-steroidal anti-inflammatory drugs and opioids, are lacking. Cannabinoids are emerging as potentially promising agents to manage neuroimmune effects associated with nociception. In particular, Δ9-tetrahydrocannabinol (THC), cannabidiol (CBD), and their combination are being considered as therapeutic alternatives for treatment of NP.
View Article and Find Full Text PDFComplement Ther Clin Pract
May 2020
Department of Health Research Methods, Evidence and Impact, Faculty of Health Sciences, McMaster University, 1280 Main Street West, Hamilton, Ontario, L8S 4K1, Canada; The Michael G. DeGroote Institute for Pain Research and Care, McMaster University, 1280 Main Street West, Hamilton, Ontario, L8S 4K1, Canada; Department of Anesthesia, McMaster University, 1280, Main Street West, Hamilton, Ontario, L8S 4K1, Canada; The Michael G. DeGroote Centre for Medicinal Cannabis Research, McMaster University, 1280 Main Street West, Hamilton, Ontario, L8S 4K1, Canada. Electronic address:
Background: The use of natural health products (NHPs) is common in North America. In 2003, we found that 42% of NHP users had not disclosed this information to their primary care medical doctors (MDs). We repeated our survey in 2018/2019 to explore if the rate of NHP use disclosure had improved.
View Article and Find Full Text PDFJ Clin Epidemiol
July 2020
Chinese Evidence-Based Medicine Center, Cochrane China Center and National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China; Evidence-Based Medicine Research Center, School of Basic Science, Jiangxi University of Traditional Chinese Medicine, Nanchang 330004, Jiangxi, China. Electronic address:
Objectives: This study aimed to examine the design, conduct, and analysis of systematic reviews assessing drug safety through a cross-sectional survey.
Study Design And Setting: We searched PubMed to identity systematic reviews published in the Cochrane Database of Systematic Reviews and Core Clinical Journals indexed in 2015 and randomly sampled systematic reviews assessing drug effects at a 1:1 ratio of Cochrane and non-Cochrane reviews. Teams of two investigators independently conducted study screening and collected data, using prespecified, standardized questionnaires.
BMJ
April 2020
Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada
J Occup Environ Med
May 2020
Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada (Dr Rehman, Mr Jones, Dr Madden, Ms Heels-Ansdell, Dr Busse); Canadian Academy of Osteopathy, Hamilton, Ontario, Canada (Dr Rehman); The Michael G. DeGroote Institute for Pain Research and Care, McMaster University, Hamilton, Ontario, Canada (Dr Rehman, Dr Busse); Centre for Evidence-Based Orthopedics, McMaster University, Hamilton, Ontario, Canada (Dr Madden); Department of Anesthesia, McMaster University, Hamilton, Ontario, Canada (Dr Busse) and The Michael G. DeGroote Centre for Medicinal Cannabis Research, McMaster University, Hamilton, Ontario, Canada (Dr Busse).
Objectives: We explored the association of compensation status with return to work (RTW) after tibial fracture.
Methods: Eligible patients were adults with tibial shaft fractures enrolled in the Trial to Re-evaluate Ultrasound in the Treatment of Tibial Fractures. We explored the association between disability benefits and/or litigation and RTW using multivariable discrete interval hazard analysis, adjusting for sex, age, country of residence, smoking status, body mass index, polytrauma, fracture severity, fracture gap, pain severity, and physical functioning.
Pain Res Manag
August 2020
Canadian Medical Association, Ottawa, ON, Canada.
Background: Physician adherence to guideline recommendations for the use of opioids to manage chronic pain is often limited.
Objective: In February 2018, we administered a 28-item online survey to explore perceptions of the 2017 Canadian guideline for opioid therapy and chronic noncancer pain and if physicians had altered practices in response to recommendations.
Results: We invited 34,322 Canadian physicians to complete our survey, and 1,128 responded for a response rate of 3%; 687 respondents indicated they prescribed opioids for noncancer pain and answered survey questions about the guideline and their practice.
Mol Pain
February 2021
Michael G. DeGroote Institute for Pain Research and Care, McMaster University, Hamilton, ON, Canada.
We previously identified that several cancer cell lines known to induce nociception in mouse models release glutamate in vitro. Although the mechanisms of glutamatergic signalling have been characterized primarily in the central nervous system, its importance in the peripheral nervous system has been recognized in various pathologies, including cancer pain. We therefore investigated the effect of glutamate on intracellular electrophysiological characteristics of peripheral sensory neurons in an immunocompetent rat model of cancer-induced pain based on surgical implantation of mammary rat metastasis tumour-1 cells into the distal epiphysis of the right femur.
View Article and Find Full Text PDFCan J Pain
February 2020
Michael G. DeGroote Institute for Pain Research and Care, Medicine, McMaster University, Hamilton, Ontario, Canada.
: Cancer pain involves nervous system damage and pathological neurogenesis. Neuropathic pain arises from damage to the nervous system and is driven by ectopic signaling. Both progesterone and pregabalin are neuroprotective in animal models, and there is evidence that both drugs bind to and inhibit voltage-gated calcium channels.
View Article and Find Full Text PDFJ Pain Res
February 2020
Department of Pathology & Molecular Medicine, McMaster University, Hamilton, Ontario, Canada.
Background And Aim: Cancers originating in the breast, lung and prostate often metastasize to the bone, frequently resulting in cancer-induced bone pain that can be challenging to manage despite conventional analgesic therapy. This exploratory study's aim was to identify potential biomarkers associated with cancer-induced pain by examining a sample population of breast cancer patients undergoing bisphosphonate therapy.
Methods: A secondary analysis of the primary study was performed to quantify serum cytokine levels for correlation to pain scores.
Clin J Pain
May 2020
Departments of Anesthesia.
Objectives: Opioid-induced hyperalgesia (OIH) is a phenomenon whereby opioids increase patients' pain sensitivity, complicating their use in analgesia. We explored practitioners' attitudes towards, and knowledge concerning diagnosis, risk factors, and treatment of OIH.
Materials And Methods: We administered an 18-item cross-sectional survey to 850 clinicians that managed chronic pain with opioid therapy.
Br J Pharmacol
June 2020
Michael G. DeGroote Institute for Pain Research and Care, McMaster University, Hamilton, Ontario, Canada.
Background And Purpose: Chronic neuropathic pain (NEP) is associated with growing therapeutic cannabis use. To promote quality of life without psychotropic effects, cannabinoids other than Δ9-tetrahydrocannabidiol, including cannabidiol and its precursor cannabidiolic acid (CBDA), are being evaluated. Due to its instability, CBDA has been understudied, particularly as an anti-nociceptive agent.
View Article and Find Full Text PDFEur Radiol
April 2020
Department of Radiology, McMaster University, St. Joseph's Healthcare, Hamilton, ON, Canada.
Objectives: No consensus exists on digital breast tomosynthesis (DBT) utilization for breast cancer detection. We performed a diagnostic test accuracy systematic review and meta-analysis comparing DBT, combined DBT and digital mammography (DM), and DM alone for breast cancer detection in average-risk women.
Methods: MEDLINE and EMBASE were searched until September 2018.
Somatosens Mot Res
March 2020
Michael G. DeGroote Institute for Pain Research and Care, McMaster University, Hamilton, ON, Canada.
Allodynia is a common feature of neuropathic pain with few validated clinical evaluation options. We identified a need to estimate the measurement properties of the standardised evaluation procedure for static mechanical allodynia severity popularised by the somatosensory rehabilitation of pain method, known as the rainbow pain scale. This study (www.
View Article and Find Full Text PDFMedicine (Baltimore)
October 2019
Department of Health Research Methods, Evidence, and Impact.
Background: Opioids are frequently prescribed for the management of patients with chronic non-cancer pain (CNCP). Previous meta-analyses of efficacy and harms have combined treatment effects across all opioids; however, specific opioids, pharmacokinetic properties (ie, long acting vs short acting), or the type of formulation (ie, immediate vs extended release) may be a source of heterogeneity for pooled effects.
Methods: We will conduct a network meta-analysis (NMA) of randomized controlled trials evaluating opioids for CNCP.
Pain Rep
May 2019
Department of Pathology and Molecular Medicine, Michael G. DeGroote Institute for Pain Research and Care, Medicine, McMaster University, Hamilton, ON, Canada.
Introduction: Microglial cells, the resident macrophages of the central nervous system, are a key contributor to the generation and maintenance of cancer-induced pain (CIP). In healthy organisms, activated microglia promote recovery through the release of trophic and anti-inflammatory factors to clear toxins and pathogens and support neuronal survival. Chronically activated microglia, however, release toxic substances, including excess glutamate, causing cytotoxicity.
View Article and Find Full Text PDFCan Med Educ J
July 2019
Department of Health Research Methods, Evidence & Impact, McMaster University, Ontario, Canada.
Background: We previously reported on a cross-sectional study of students from the Michael G. DeGroote School of Medicine at McMaster University that found most respondents wanted more opportunities to participate in research. Students provided additional comments that we synthesized to enrich the findings of our quantitative analysis.
View Article and Find Full Text PDFCan J Pain
July 2019
The Michael G. DeGroote Institute for Pain Research and Care, McMaster University, Hamilton, Ontario, Canada.
: Approximately half of all patients who undergo surgical repair of extremity fractures report persistent postsurgical pain (PPSP) at 1-year post-surgery. Psychological factors such as anxiety, depression, catastrophization, poor coping, high somatic complaints, and pessimism about recovery are risk factors for the development of PPSP. It is possible that interventions such as cognitive behavior therapy (CBT) that target psychological factors may reduce the incidence of PPSP in this population.
View Article and Find Full Text PDFCan J Pain
July 2019
Michael G. DeGroote Institute for Pain Research and Care, McMaster University, Hamilton, Ontario, Canada.
: Considering the poorly understood etiology and complex symptoms of chronic neuropathic pain (NP), the lack of effective treatments, and sex-dependent differences in the neuroimmune system as well as in antinociceptive responses to existing pharmacological agents, the potential to therapeutically target the endocannabinoid system as a means of treating this type of intractable pain is clinically relevant and timely. Chronic NP may involve the utilization of distinct immune cell populations in males and females that differentially affect supraspinal and spinal neuromodulation. It is therefore important to investigate the effects of cannabidiol (CBD) on chronic NP-induced nociceptive responses in both sexes.
View Article and Find Full Text PDF